Titre : Mycoses

Mycoses : Questions médicales fréquentes

Nom anglais: Mycoses

Descriptor UI: D009181

Tree Number: C01.150.703

Termes MeSH sélectionnés :

Patient Preference

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostique-t-on une mycose ?

Le diagnostic repose sur l'examen clinique et des tests de laboratoire, comme des cultures.
Mycoses Diagnostic médical
#2

Quels tests sont utilisés pour identifier une mycose ?

Des prélèvements cutanés, des biopsies et des examens microscopiques sont courants.
Mycoses Biopsie
#3

Les mycoses peuvent-elles être confondues avec d'autres maladies ?

Oui, elles peuvent être confondues avec des infections bactériennes ou des dermatites.
Mycoses Dermatite
#4

Quels signes cliniques indiquent une mycose ?

Rougeur, démangeaisons, desquamation et lésions cutanées sont des signes fréquents.
Mycoses Symptômes
#5

Les tests sanguins sont-ils utiles pour les mycoses ?

Ils peuvent aider à détecter des infections systémiques, mais ne sont pas toujours nécessaires.
Mycoses Tests sanguins

Symptômes 5

#1

Quels sont les symptômes courants des mycoses cutanées ?

Démangeaisons, rougeurs, éruptions cutanées et desquamation sont fréquents.
Mycoses Symptômes
#2

Les mycoses provoquent-elles de la douleur ?

Elles peuvent causer de l'inconfort, mais la douleur n'est pas toujours présente.
Mycoses Douleur
#3

Les mycoses peuvent-elles affecter les ongles ?

Oui, les mycoses des ongles, appelées onychomycoses, sont courantes et visibles.
Mycoses Onychomycose
#4

Quels symptômes indiquent une mycose systémique ?

Fièvre, fatigue, et symptômes respiratoires peuvent indiquer une mycose systémique.
Mycoses Infection systémique
#5

Les mycoses peuvent-elles causer des problèmes respiratoires ?

Certaines mycoses, comme l'aspergillose, peuvent affecter les poumons et causer des symptômes respiratoires.
Mycoses Aspergillose

Prévention 5

#1

Comment prévenir les mycoses cutanées ?

Maintenir une bonne hygiène, garder la peau sèche et éviter les environnements humides aide.
Mycoses Prévention
#2

Les chaussures peuvent-elles favoriser les mycoses ?

Oui, des chaussures fermées et humides augmentent le risque de mycoses des pieds.
Mycoses Chaussures
#3

Les personnes immunodéprimées doivent-elles être plus prudentes ?

Oui, elles sont plus susceptibles de développer des mycoses et doivent prendre des précautions.
Mycoses Immunodépression
#4

L'alimentation influence-t-elle le risque de mycoses ?

Une alimentation équilibrée peut renforcer le système immunitaire et réduire le risque.
Mycoses Alimentation
#5

Les mycoses peuvent-elles être évitées par des vaccins ?

Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les mycoses.
Mycoses Vaccins

Traitements 5

#1

Quels traitements sont disponibles pour les mycoses ?

Les antifongiques topiques ou systémiques sont utilisés selon la gravité de l'infection.
Mycoses Antifongiques
#2

Les mycoses cutanées nécessitent-elles des médicaments oraux ?

Pas toujours, mais des antifongiques oraux peuvent être prescrits pour les cas sévères.
Mycoses Antifongiques
#3

Combien de temps dure le traitement des mycoses ?

La durée varie de quelques semaines à plusieurs mois, selon le type et la gravité.
Mycoses Durée du traitement
#4

Les remèdes maison sont-ils efficaces contre les mycoses ?

Certains remèdes peuvent soulager, mais ils ne remplacent pas un traitement médical approprié.
Mycoses Remèdes maison
#5

Les mycoses peuvent-elles récidiver après traitement ?

Oui, les récidives sont possibles, surtout si les facteurs de risque persistent.
Mycoses Récidive

Complications 5

#1

Quelles complications peuvent survenir avec les mycoses ?

Des infections secondaires, des allergies et des complications systémiques peuvent survenir.
Mycoses Complications
#2

Les mycoses peuvent-elles être mortelles ?

Certaines mycoses systémiques peuvent être graves et potentiellement mortelles, surtout chez les immunodéprimés.
Mycoses Infection systémique
#3

Comment les mycoses affectent-elles la qualité de vie ?

Elles peuvent causer des douleurs, des démangeaisons et des problèmes psychologiques liés à l'apparence.
Mycoses Qualité de vie
#4

Les mycoses peuvent-elles entraîner des infections bactériennes ?

Oui, les lésions cutanées causées par des mycoses peuvent être une porte d'entrée pour des infections bactériennes.
Mycoses Infections bactériennes
#5

Les mycoses peuvent-elles affecter d'autres organes ?

Certaines mycoses, comme la candidose, peuvent affecter les organes internes et provoquer des complications.
Mycoses Candidose

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque des mycoses ?

L'humidité, le diabète, l'immunodépression et l'utilisation excessive d'antibiotiques augmentent le risque.
Mycoses Facteurs de risque
#2

Le diabète influence-t-il le risque de mycoses ?

Oui, le diabète peut affaiblir le système immunitaire et favoriser les infections fongiques.
Mycoses Diabète
#3

Les traitements antibiotiques augmentent-ils le risque de mycoses ?

Oui, ils peuvent perturber la flore normale et favoriser la prolifération de champignons.
Mycoses Antibiotiques
#4

Les personnes âgées sont-elles plus à risque de mycoses ?

Oui, le vieillissement peut affaiblir le système immunitaire, augmentant le risque d'infections fongiques.
Mycoses Personnes âgées
#5

Le stress peut-il contribuer aux mycoses ?

Oui, le stress chronique peut affaiblir le système immunitaire et augmenter le risque d'infections.
Mycoses Stress
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mycoses : Questions médicales les plus fréquentes", "headline": "Mycoses : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mycoses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-23", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mycoses" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections bactériennes et mycoses", "url": "https://questionsmedicales.fr/mesh/D001423", "about": { "@type": "MedicalCondition", "name": "Infections bactériennes et mycoses", "code": { "@type": "MedicalCode", "code": "D001423", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aspergillose", "alternateName": "Aspergillosis", "url": "https://questionsmedicales.fr/mesh/D001228", "about": { "@type": "MedicalCondition", "name": "Aspergillose", "code": { "@type": "MedicalCode", "code": "D001228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.080" } } }, { "@type": "MedicalWebPage", "name": "Candidose", "alternateName": "Candidiasis", "url": "https://questionsmedicales.fr/mesh/D002177", "about": { "@type": "MedicalCondition", "name": "Candidose", "code": { "@type": "MedicalCode", "code": "D002177", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.160" } } }, { "@type": "MedicalWebPage", "name": "Coccidioïdomycose", "alternateName": "Coccidioidomycosis", "url": "https://questionsmedicales.fr/mesh/D003047", "about": { "@type": "MedicalCondition", "name": "Coccidioïdomycose", "code": { "@type": "MedicalCode", "code": "D003047", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.203" } } }, { "@type": "MedicalWebPage", "name": "Cryptococcose", "alternateName": "Cryptococcosis", "url": "https://questionsmedicales.fr/mesh/D003453", "about": { "@type": "MedicalCondition", "name": "Cryptococcose", "code": { "@type": "MedicalCode", "code": "D003453", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.248" } } }, { "@type": "MedicalWebPage", "name": "Géotrichose", "alternateName": "Geotrichosis", "url": "https://questionsmedicales.fr/mesh/D005847", "about": { "@type": "MedicalCondition", "name": "Géotrichose", "code": { "@type": "MedicalCode", "code": "D005847", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.392" } } }, { "@type": "MedicalWebPage", "name": "Histoplasmose", "alternateName": "Histoplasmosis", "url": "https://questionsmedicales.fr/mesh/D006660", "about": { "@type": "MedicalCondition", "name": "Histoplasmose", "code": { "@type": "MedicalCode", "code": "D006660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.450" } } }, { "@type": "MedicalWebPage", "name": "Infections fongiques invasives", "alternateName": "Invasive Fungal Infections", "url": "https://questionsmedicales.fr/mesh/D000072742", "about": { "@type": "MedicalCondition", "name": "Infections fongiques invasives", "code": { "@type": "MedicalCode", "code": "D000072742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.492" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Candidose invasive", "alternateName": "Candidiasis, Invasive", "url": "https://questionsmedicales.fr/mesh/D058365", "about": { "@type": "MedicalCondition", "name": "Candidose invasive", "code": { "@type": "MedicalCode", "code": "D058365", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.492.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Microsporidiose", "alternateName": "Microsporidiosis", "url": "https://questionsmedicales.fr/mesh/D016881", "about": { "@type": "MedicalCondition", "name": "Microsporidiose", "code": { "@type": "MedicalCode", "code": "D016881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.617" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Encéphalitozoonose", "alternateName": "Encephalitozoonosis", "url": "https://questionsmedicales.fr/mesh/D016890", "about": { "@type": "MedicalCondition", "name": "Encéphalitozoonose", "code": { "@type": "MedicalCode", "code": "D016890", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.617.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Blastomycose sud-américaine", "alternateName": "Paracoccidioidomycosis", "url": "https://questionsmedicales.fr/mesh/D010229", "about": { "@type": "MedicalCondition", "name": "Blastomycose sud-américaine", "code": { "@type": "MedicalCode", "code": "D010229", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.700" } } }, { "@type": "MedicalWebPage", "name": "Phaeohyphomycose", "alternateName": "Phaeohyphomycosis", "url": "https://questionsmedicales.fr/mesh/D060446", "about": { "@type": "MedicalCondition", "name": "Phaeohyphomycose", "code": { "@type": "MedicalCode", "code": "D060446", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.726" } } }, { "@type": "MedicalWebPage", "name": "Infections à Pneumocystis", "alternateName": "Pneumocystis Infections", "url": "https://questionsmedicales.fr/mesh/D016720", "about": { "@type": "MedicalCondition", "name": "Infections à Pneumocystis", "code": { "@type": "MedicalCode", "code": "D016720", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.770" } } }, { "@type": "MedicalWebPage", "name": "Zygomycose", "alternateName": "Zygomycosis", "url": "https://questionsmedicales.fr/mesh/D020096", "about": { "@type": "MedicalCondition", "name": "Zygomycose", "code": { "@type": "MedicalCode", "code": "D020096", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.980" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mucormycose", "alternateName": "Mucormycosis", "url": "https://questionsmedicales.fr/mesh/D009091", "about": { "@type": "MedicalCondition", "name": "Mucormycose", "code": { "@type": "MedicalCode", "code": "D009091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.703.980.600" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Mycoses", "alternateName": "Mycoses", "code": { "@type": "MedicalCode", "code": "D009181", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Dimitrios P Kontoyiannis", "url": "https://questionsmedicales.fr/author/Dimitrios%20P%20Kontoyiannis", "affiliation": { "@type": "Organization", "name": "University of Texas MD Anderson Cancer Center, Houston, Texas, USA." } }, { "@type": "Person", "name": "Alexandro Bonifaz", "url": "https://questionsmedicales.fr/author/Alexandro%20Bonifaz", "affiliation": { "@type": "Organization", "name": "Dermatology Service & Micology Department, Hospital General de México \"Dr Eduardo Liceaga\", Dr. Balmis 148, colonia Doctores, PZ: 06720 Mexico City, Mexico." } }, { "@type": "Person", "name": "Alessandro C Pasqualotto", "url": "https://questionsmedicales.fr/author/Alessandro%20C%20Pasqualotto", "affiliation": { "@type": "Organization", "name": "Radiology Department, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre 90020-090, Brazil." } }, { "@type": "Person", "name": "George R Thompson", "url": "https://questionsmedicales.fr/author/George%20R%20Thompson", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Patient preference predictor and the objection from higher-order preferences.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35777961", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/jme-2022-108427" } }, { "@type": "ScholarlyArticle", "name": "Cultural Differences in Patients' Preferences for Paternalism: Comparing Mexican and American Patients' Preferences for and Experiences with Physician Paternalism and Patient Autonomy.", "datePublished": "2022-08-26", "url": "https://questionsmedicales.fr/article/36078378", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph191710663" } }, { "@type": "ScholarlyArticle", "name": "A stated preference survey to explore patient preferences for novel preventive migraine treatments.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36047857", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/head.14386" } }, { "@type": "ScholarlyArticle", "name": "Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.", "datePublished": "2022-07-29", "url": "https://questionsmedicales.fr/article/35904149", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0272989X221115058" } }, { "@type": "ScholarlyArticle", "name": "Patient Preferences for Lung Cancer Interception Therapy.", "datePublished": "2023-11-01", "url": "https://questionsmedicales.fr/article/37948077", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.42681" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Infections bactériennes et mycoses", "item": "https://questionsmedicales.fr/mesh/D001423" }, { "@type": "ListItem", "position": 4, "name": "Mycoses", "item": "https://questionsmedicales.fr/mesh/D009181" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mycoses - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mycoses", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mycoses", "description": "Comment diagnostique-t-on une mycose ?\nQuels tests sont utilisés pour identifier une mycose ?\nLes mycoses peuvent-elles être confondues avec d'autres maladies ?\nQuels signes cliniques indiquent une mycose ?\nLes tests sanguins sont-ils utiles pour les mycoses ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mycoses", "description": "Quels sont les symptômes courants des mycoses cutanées ?\nLes mycoses provoquent-elles de la douleur ?\nLes mycoses peuvent-elles affecter les ongles ?\nQuels symptômes indiquent une mycose systémique ?\nLes mycoses peuvent-elles causer des problèmes respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mycoses", "description": "Comment prévenir les mycoses cutanées ?\nLes chaussures peuvent-elles favoriser les mycoses ?\nLes personnes immunodéprimées doivent-elles être plus prudentes ?\nL'alimentation influence-t-elle le risque de mycoses ?\nLes mycoses peuvent-elles être évitées par des vaccins ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mycoses", "description": "Quels traitements sont disponibles pour les mycoses ?\nLes mycoses cutanées nécessitent-elles des médicaments oraux ?\nCombien de temps dure le traitement des mycoses ?\nLes remèdes maison sont-ils efficaces contre les mycoses ?\nLes mycoses peuvent-elles récidiver après traitement ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mycoses", "description": "Quelles complications peuvent survenir avec les mycoses ?\nLes mycoses peuvent-elles être mortelles ?\nComment les mycoses affectent-elles la qualité de vie ?\nLes mycoses peuvent-elles entraîner des infections bactériennes ?\nLes mycoses peuvent-elles affecter d'autres organes ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mycoses", "description": "Quels sont les principaux facteurs de risque des mycoses ?\nLe diabète influence-t-il le risque de mycoses ?\nLes traitements antibiotiques augmentent-ils le risque de mycoses ?\nLes personnes âgées sont-elles plus à risque de mycoses ?\nLe stress peut-il contribuer aux mycoses ?", "url": "https://questionsmedicales.fr/mesh/D009181?mesh_terms=Patient+Preference#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une mycose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des tests de laboratoire, comme des cultures." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier une mycose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des prélèvements cutanés, des biopsies et des examens microscopiques sont courants." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles être confondues avec d'autres maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être confondues avec des infections bactériennes ou des dermatites." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une mycose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, démangeaisons, desquamation et lésions cutanées sont des signes fréquents." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour les mycoses ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à détecter des infections systémiques, mais ne sont pas toujours nécessaires." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des mycoses cutanées ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Démangeaisons, rougeurs, éruptions cutanées et desquamation sont fréquents." } }, { "@type": "Question", "name": "Les mycoses provoquent-elles de la douleur ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent causer de l'inconfort, mais la douleur n'est pas toujours présente." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles affecter les ongles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les mycoses des ongles, appelées onychomycoses, sont courantes et visibles." } }, { "@type": "Question", "name": "Quels symptômes indiquent une mycose systémique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, et symptômes respiratoires peuvent indiquer une mycose systémique." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles causer des problèmes respiratoires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mycoses, comme l'aspergillose, peuvent affecter les poumons et causer des symptômes respiratoires." } }, { "@type": "Question", "name": "Comment prévenir les mycoses cutanées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, garder la peau sèche et éviter les environnements humides aide." } }, { "@type": "Question", "name": "Les chaussures peuvent-elles favoriser les mycoses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des chaussures fermées et humides augmentent le risque de mycoses des pieds." } }, { "@type": "Question", "name": "Les personnes immunodéprimées doivent-elles être plus prudentes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont plus susceptibles de développer des mycoses et doivent prendre des précautions." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de mycoses ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut renforcer le système immunitaire et réduire le risque." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles être évitées par des vaccins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les mycoses." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les mycoses ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antifongiques topiques ou systémiques sont utilisés selon la gravité de l'infection." } }, { "@type": "Question", "name": "Les mycoses cutanées nécessitent-elles des médicaments oraux ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des antifongiques oraux peuvent être prescrits pour les cas sévères." } }, { "@type": "Question", "name": "Combien de temps dure le traitement des mycoses ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie de quelques semaines à plusieurs mois, selon le type et la gravité." } }, { "@type": "Question", "name": "Les remèdes maison sont-ils efficaces contre les mycoses ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains remèdes peuvent soulager, mais ils ne remplacent pas un traitement médical approprié." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles récidiver après traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les récidives sont possibles, surtout si les facteurs de risque persistent." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les mycoses ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections secondaires, des allergies et des complications systémiques peuvent survenir." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mycoses systémiques peuvent être graves et potentiellement mortelles, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Comment les mycoses affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent causer des douleurs, des démangeaisons et des problèmes psychologiques liés à l'apparence." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles entraîner des infections bactériennes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lésions cutanées causées par des mycoses peuvent être une porte d'entrée pour des infections bactériennes." } }, { "@type": "Question", "name": "Les mycoses peuvent-elles affecter d'autres organes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mycoses, comme la candidose, peuvent affecter les organes internes et provoquer des complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque des mycoses ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'humidité, le diabète, l'immunodépression et l'utilisation excessive d'antibiotiques augmentent le risque." } }, { "@type": "Question", "name": "Le diabète influence-t-il le risque de mycoses ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut affaiblir le système immunitaire et favoriser les infections fongiques." } }, { "@type": "Question", "name": "Les traitements antibiotiques augmentent-ils le risque de mycoses ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent perturber la flore normale et favoriser la prolifération de champignons." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de mycoses ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affaiblir le système immunitaire, augmentant le risque d'infections fongiques." } }, { "@type": "Question", "name": "Le stress peut-il contribuer aux mycoses ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affaiblir le système immunitaire et augmenter le risque d'infections." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale

Validation scientifique effectuée le 19/04/2025

Contenu vérifié selon les dernières recommandations médicales

En savoir plus sur Dr Menir

Sous-catégories

15 au total
└─

Aspergillose

Aspergillosis D001228 - C01.150.703.080
└─

Candidose

Candidiasis D002177 - C01.150.703.160
└─

Coccidioïdomycose

Coccidioidomycosis D003047 - C01.150.703.203
└─

Cryptococcose

Cryptococcosis D003453 - C01.150.703.248
└─

Géotrichose

Geotrichosis D005847 - C01.150.703.392
└─

Histoplasmose

Histoplasmosis D006660 - C01.150.703.450
└─

Infections fongiques invasives

Invasive Fungal Infections D000072742 - C01.150.703.492
└─

Microsporidiose

Microsporidiosis D016881 - C01.150.703.617
└─

Blastomycose sud-américaine

Paracoccidioidomycosis D010229 - C01.150.703.700
└─

Phaeohyphomycose

Phaeohyphomycosis D060446 - C01.150.703.726
└─

Infections à Pneumocystis

Pneumocystis Infections D016720 - C01.150.703.770
└─

Zygomycose

Zygomycosis D020096 - C01.150.703.980
└─└─

Candidose invasive

Candidiasis, Invasive D058365 - C01.150.703.492.500
└─└─

Encéphalitozoonose

Encephalitozoonosis D016890 - C01.150.703.617.300
└─└─

Mucormycose

Mucormycosis D009091 - C01.150.703.980.600

Auteurs principaux

None None

4 publications dans cette catégorie

Publications dans "Mycoses" :

Dimitrios P Kontoyiannis

3 publications dans cette catégorie

Affiliations :
  • University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publications dans "Mycoses" :

Alexandro Bonifaz

3 publications dans cette catégorie

Affiliations :
  • Dermatology Service & Micology Department, Hospital General de México "Dr Eduardo Liceaga", Dr. Balmis 148, colonia Doctores, PZ: 06720 Mexico City, Mexico.
Publications dans "Mycoses" :

Alessandro C Pasqualotto

3 publications dans cette catégorie

Affiliations :
  • Radiology Department, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre 90020-090, Brazil.
Publications dans "Mycoses" :

George R Thompson

3 publications dans cette catégorie

Affiliations :
  • Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento.
  • Department of Medical Microbiology and Immunology, University of California Davis, Davis, California, USA.
Publications dans "Mycoses" :

Cybele Lara R Abad

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Section of Infectious Diseases, University of the Philippines Manila, Philippine General Hospital, Manila, Philippines.
Publications dans "Mycoses" :

Raymund R Razonable

3 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Infectious Diseases, The William J Von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic College of Medicine and Sciences, Rochester, Minnesota, USA.
Publications dans "Mycoses" :

Thomas J Walsh

2 publications dans cette catégorie

Affiliations :
  • Hospital for Special Surgerygrid.239915.5, Weill Cornell Medicine, New York, New York, USA.
  • Weill Cornell Medicinegrid.471410.7 of Cornell University, New York, New York, USA.
  • New York Presbyterian Hospital, New York, New York, USA.
  • Center for Innovative Therapeutics and Diagnostics, Richmond, Virginia, USA.
Publications dans "Mycoses" :

Andrés Tirado-Sánchez

2 publications dans cette catégorie

Affiliations :
  • Dermatology Service & Micology Department, Hospital General de México "Dr Eduardo Liceaga", Dr. Balmis 148, colonia Doctores, PZ: 06720 Mexico City, Mexico.
Publications dans "Mycoses" :

Rodrigo Almeida-Paes

2 publications dans cette catégorie

Affiliations :
  • Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
Publications dans "Mycoses" :

Mauro de Medeiros Muniz

2 publications dans cette catégorie

Affiliations :
  • Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
Publications dans "Mycoses" :

Aditya K Gupta

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Division of Dermatology, University of Toronto School of Medicine, Toronto, Canada.
  • Mediprobe Research Inc, London, Canada.
Publications dans "Mycoses" :

Tom Chiller

2 publications dans cette catégorie

Affiliations :
  • Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publications dans "Mycoses" :

Fabrício Brito Silva

2 publications dans cette catégorie

Affiliations :
  • Mestrado em Meio Ambiente - Universidade CEUMA (UNICEUMA), São Luís, Maranhão, Brazil.
Publications dans "Mycoses" :

Jessflan Rafael Nascimento Santos

2 publications dans cette catégorie

Affiliations :
  • Mestrado em Meio Ambiente - Universidade CEUMA (UNICEUMA), São Luís, Maranhão, Brazil.
Publications dans "Mycoses" :

Letícia Chagas da Silva

2 publications dans cette catégorie

Affiliations :
  • Mestrado em Meio Ambiente - Universidade CEUMA (UNICEUMA), São Luís, Maranhão, Brazil.
Publications dans "Mycoses" :

Julliana Ribeiro Alves Santos

2 publications dans cette catégorie

Affiliations :
  • Mestrado em Meio Ambiente - Universidade CEUMA (UNICEUMA), São Luís, Maranhão, Brazil. julliana.santos85@gmail.com.
Publications dans "Mycoses" :

Allister S Lee

2 publications dans cette catégorie

Affiliations :
  • Department of Ophthalmology, Royal Brisbane and Women's Hospital (RBWH), Brisbane, QLD, Australia. allister.lee@uqconnect.edu.au.
  • University of Queensland, Brisbane, QLD, Australia. allister.lee@uqconnect.edu.au.
Publications dans "Mycoses" :

Timothy J Sullivan

2 publications dans cette catégorie

Affiliations :
  • Department of Ophthalmology, Royal Brisbane and Women's Hospital (RBWH), Brisbane, QLD, Australia.
  • University of Queensland, Brisbane, QLD, Australia.
Publications dans "Mycoses" :

David W Denning

2 publications dans cette catégorie

Affiliations :
  • Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Publications dans "Mycoses" :

Sources (10000 au total)

Cultural Differences in Patients' Preferences for Paternalism: Comparing Mexican and American Patients' Preferences for and Experiences with Physician Paternalism and Patient Autonomy.

26 08 2022
DOI: 10.3390/ijerph191710663 PMID: 36078378

Following up on previous research demonstrating the high level of care realized by a paternalistic Mexican physician, the present research further explored the hypothesis that there are cultural diffe...

Decision Making Humans Paternalism Patient Preference Personal Autonomy +2 autres

A stated preference survey to explore patient preferences for novel preventive migraine treatments.

10 2022
DOI: 10.1111/head.14386 PMID: 36047857

The objective of this study was to explore patient preference for attributes of calcitonin gene-related peptide (CGRP) inhibitors for the preventive treatment of migraine and to describe differences i... CGRP inhibitors are a novel class of migraine drugs specifically developed for the preventive treatment of migraine. Clinicians should understand patient preferences for CGRP inhibitors to inform and ... Patients with migraine in the US and Germany were recruited to participate in an online discrete choice experiment (DCE) survey, which presented hypothetical treatment choices using five attributes: m... Of 680 who consented to participate, 506 participants completed the survey and were included in the study (US = 257; Germany = 249). Overall, participants placed highest importance (preference weight,... In this DCE assessing CGRP inhibitors attributes, the main driver of patient choice was treatment effectiveness, specifically reduced migraine severity, and consistent treatment effectiveness. Further...

Humans Patient Preference Calcitonin Gene-Related Peptide Migraine Disorders Germany +1 autres

Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.

02 2023
DOI: 10.1177/0272989X221115058 PMID: 35904149

While clinical practice guidelines underscore the need to incorporate patient preferences in clinical decision making, incorporating meaningful assessment of patient preferences in clinical encounters... We propose an approach to efficiently diagnose preferences of patients for outcomes of treatment alternatives by leveraging prior information on patient preferences to generate adaptive choice questio... We identified 4 classes representing distinct preference profiles for patients who participated in a previous first-time anterior shoulder dislocation (FTASD) survey. Posterior probabilities of class ... Our results suggest that this approach could help diagnose patient preferences for treatments for a condition such as FTASD with acceptable precision using as few as 2 choice questions. Such preferenc... Approaches that combine patient preferences and clinical evidence can facilitate effective patient-provider communication and more patient-centric healthcare decisions. However, diagnosing individual-...

Humans Decision Making, Shared Patient Preference Shoulder Dislocation Surveys and Questionnaires +3 autres

Patient Preferences for Lung Cancer Interception Therapy.

01 Nov 2023
DOI: 10.1001/jamanetworkopen.2023.42681 PMID: 37948077

Interception therapy requires individuals to undergo treatment to prevent a future medical event, but little is known about preferences of individuals at high risk for lung cancer and whether they wou... To explore preferences of individuals at high risk for lung cancer for potential interception therapies to reduce this risk.... This survey study used a discrete-choice experiment and included hypothetical lung cancer interception treatments with 4 attributes: reduction in lung cancer risk over 3 years, injection site reaction... Attribute-level preference weights were estimated, and conditional relative attribute importance, maximum acceptable risks, and minimum acceptable benefits were calculated. Characteristics of responde... Of the 803 survey respondents, 495 (61.6%) were female, 138 (17.2%) were African American or Black, 55 (6.8%) were Alaska Native, American Indian, or Native American, 44 (5.5%) were Asian or Native Ha... In this survey study of individuals at high risk of lung cancer, most respondents were willing to consider interception therapy. These results suggest the importance of benefit-risk assessments for fu...

Adult Humans Female Male Lung Neoplasms +4 autres

Adaptation of the WOMAC for Use in a Patient Preference Study.

Jul 2023
DOI: 10.1007/s43441-023-00510-8 PMID: 37061632

To adapt a patient-reported outcome (PRO) measure, the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), into efficacy attributes for a discrete choice experiment (DCE) survey design... The adaptation comprised four steps: (1) selecting domains of interest; (2) determining presentation and framing of selected attributes; (3) determining attribute levels; and (4) developing choice tas... The WOMAC pain and function domains were selected for adaption to two efficacy attributes. Two versions of the discrete choice experiment (DCE) instrument were created to compare efficacy using (1) to... This study adds to the growing literature regarding adapting PRO measures for patient preference studies. Such adaptation is important for designing a preference study that can incorporate a clinical ...

Humans Female Middle Aged Male Patient Preference +4 autres

Patient Preferences for Waiting Time and Kidney Quality.

09 2022
DOI: 10.2215/CJN.01480222 PMID: 35985699

Approximately 20% of deceased donor kidneys are discarded each year in the United States. Some of these kidneys could benefit patients who are waitlisted. Understanding patient preferences regarding a... This study uses a discrete choice experiment that presents a deceased donor kidney to patients who are waiting for, or have received, a kidney transplant. The choices involve trade-offs between accept... In total, 605 participants completed the discrete choice experiment. Respondents made trade-offs between kidney quality and waiting time. The average respondent would accept a kidney today, with 6.5 y... Participants preferred accepting a lower-quality kidney in return for shorter waiting time, particularly those who were older and had lower functional status....

Humans United States Middle Aged Kidney Failure, Chronic Patient Preference +4 autres

Preference of acromegaly patients for treatment attributes in Spain.

11 2023
DOI: 10.1007/s12020-023-03462-z PMID: 37507554

Acromegaly is a rare disease caused by increased growth hormone secretion and a subsequent increase in insulin-like growth factor I (IGF-I) levels. Patients display multiple comorbidities that affect ... A cross-sectional study based on interviews and a discrete choice experiment (DCE) in a Spanish cohort.... Adult patients diagnosed with acromegaly ≥1 year before the start of the study and under treatment were included. Treatment attributes were collected from patient testimony during face-to-face intervi... Sixty-seven patients completed the study. QoL improvement was the most important treatment attribute (37%), followed by IGF-I control (20%), blood sugar control (17%) and tumour control (13%). Seconda... QoL greatly influences patient treatment preference. Since acromegaly patients are informed and aware of their disease, treatment choices should always be shared with patients....

Adult Humans Quality of Life Insulin-Like Growth Factor I Acromegaly +3 autres

How culture influences patient preferences for patient-centered care with their doctors.

07 2023
DOI: 10.1080/17538068.2022.2095098 PMID: 37401877

Patient-centered care (PCC) is the prevailing model of care globally. However, most research on PCC has been conducted in Westernized countries or has focused on only two facets of PCC: decision-makin... Participants (... Participants from all four countries had similar preferences for empathy and shared decision-making. For other facets of PCC, participants in the Philippines and Australia expressed somewhat similar p... Empathy, information exchange, and shared decision-making are values shared across countries, while preferences for how the information is shared, and the importance of the doctor-patient relationship...

Humans Patient Preference Physician-Patient Relations Decision Making Australia +1 autres

Understanding treatment preferences and cognitive outcomes in patients with gliomas.

18 Sep 2024
DOI: 10.1007/s00520-024-08876-7 PMID: 39292365

Understanding how glioma patients value cognitive outcomes is essential to personalizing their treatment plans. The purpose of this study was to identify the modifiable cognitive functions most affect... Patients with gliomas were prospectively enrolled in focus groups and individual interviews using a standardized guide focusing on cognitive functions until saturation was achieved. Patient values and... Twenty participants participated, of whom 60% were female. Racial identification consisted of 75% White, 15% Black/African American, and 10% Other Racial Identification. The cognitive functions most e... Glioma patients in this study prioritized cognitive functions according to memory, personal identity, and their ability to communicate with loved ones independently of experiencing deficits in these f...

Humans Glioma Female Male Quality of Life +8 autres